Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population

被引:0
|
作者
Moriyama, Kengo [1 ]
Inoue, Nagamu [1 ]
Imai, Jin [2 ]
Masuda, Yumi [3 ]
Yamada, Chizumi [3 ]
Kishimoto, Noriaki [3 ]
Takashimizu, Shinji [2 ]
Kubo, Akira [3 ]
Nishizaki, Yasuhiro [2 ]
机构
[1] Tokai Univ, Hachioji Hosp, Dept Clin Hlth Sci, Sch Med, Tokyo, Japan
[2] Tokai Univ, Dept Clin Hlth Sci, Sch Med, Hiratsuka, Kanagawa, Japan
[3] Tokai Univ, Sch Med, Dept Clin Hlth Sci, Tokyo Hosp, Tokyo, Japan
基金
日本学术振兴会;
关键词
metabolic dysfunction-associated fatty liver disease; triglyceride to high-density lipoprotein cholesterol ratio; alanine aminotransferase; insulin resistance; triglyceride-glucose index; annual health examination; HOMEOSTASIS MODEL ASSESSMENT; TRIGLYCERIDE-GLUCOSE INDEX; ETHNIC-DIFFERENCES; MANAGEMENT; PRODUCT;
D O I
10.1089/met.2023.0116
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Recently, metabolic dysfunction-associated fatty liver disease (MAFLD), which is based on evidence of hepatic steatosis and any of the following three conditions: overweight/obesity, presence of type 2 diabetes mellitus, or evidence of metabolic dysregulation, has been proposed. It is uncertain how indices that predict insulin resistance (IR) are associated with MAFLD. Methods: Among subjects who had undergone health examinations at our hospital, 1,257 (787 men and 474 women) who underwent fatty liver evaluation, were included in this cross-sectional study. The discriminatory ability of each index for MAFLD was tested using a receiver operating characteristic curve analysis. The associations between the homeostasis model assessment-IR (HOMA-IR), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, triglyceride-glucose (TyG) index, and MAFLD were investigated using multiple logistic regression analysis. Results: The mean age and body mass index of MAFLD subjects were 58.1 years and 26.0kg/m(2) in men and 63.0 years and 26.1kg/m(2) in women, respectively. The cutoff values of HOMA-IR, TG/HDL-C ratio, and TyG index in men and women were 1.40 (area under the curve [AUC]: 0.81) and 1.90 (AUC: 0.88); 1.56 (AUC: 0.75) and 1.06 (AUC: 0.78); and 8.62 (AUC: 0.75) and 8.45 (AUC: 0.80), respectively. All indices were significantly higher in both men and women with MAFLD. In the multivariate models, the odds of MAFLD were higher among both men and women in the highest tertile than those in the lowest tertile. When subjects were divided by sex, presence of MAFLD, and alanine aminotransferase (ALT) values, all indices were significantly higher in both men and women with high ALT levels who were diagnosed with MAFLD. Conclusion: IR strongly correlated with MAFLD, particularly in subjects with high ALT levels.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [41] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation
    Carnagarin, Revathy
    Tan, Kearney
    Adams, Leon
    Matthews, Vance B.
    Kiuchi, Marcio G.
    Marisol Lugo Gavidia, Leslie
    Lambert, Gavin W.
    Lambert, Elisabeth A.
    Herat, Lakshini Y.
    Schlaich, Markus P.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (08)
  • [42] Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
    Chun, Ho Soo
    Kim, Mi Na
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Kim, Seung Up
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2021, 12 (05) : 1168 - 1178
  • [43] Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
    Huang, Jee-Fu
    Tsai, Pei-Chien
    Yeh, Ming-Lun
    Huang, Chung-Feng
    Huang, Ching-, I
    Lee, Mei-Hsuan
    Hsu, Po-Yau
    Wang, Chih-Wen
    Wei, Yu-Ju
    Liang, Po-Cheng
    Lin, Yi-Hung
    Hsieh, Meng-Hsuan
    Yang, Jeng-Fu
    Hsieh, Ming-Yen
    Jang, Tyng-Yuan
    Bair, Ming-Jong
    Lin, Zu-Yau
    Dai, Chia-Yen
    Yu, Ming-Lung
    Chuang, Wan-Long
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2023, 11 (05) : 1061 - 1068
  • [44] Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
    Lopes Vasques-Monteiro, Isabela Macedo
    Souza-Mello, Vanessa
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (16) : 1738 - 1750
  • [45] Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients
    Bockarie, A. S.
    Nartey, Y. A.
    Nsiah, P.
    Edzie, E. K. M.
    Tuoyire, D.
    Acquah, S.
    Eliason, S.
    Nkum, B.
    ENDOCRINOLOGY DIABETES & METABOLISM, 2023, 6 (06)
  • [46] Impact of Thyroid Function on the Prevalence and Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease
    Chen, Yu-ling
    Tian, Shen
    Wu, Juan
    Li, Hao
    Li, Shu
    Xu, Zhou
    Liang, Xin-yu
    Adhikari, Vishnu Prasad
    Xiao, Jun
    Song, Jing-yu
    Ma, Chen-yu
    She, Rui-ling
    Li, Zhao-xing
    Wu, Kai-nan
    Kong, Ling-quan
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07) : E434 - E443
  • [47] The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review
    Mohammadian, Kiana
    Fakhar, Fatemeh
    Keramat, Shayan
    Stanek, Agata
    ANTIOXIDANTS, 2024, 13 (07)
  • [48] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [49] Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
    Castillo-Nunez, Yulino
    Almeda-Valdes, Paloma
    Gonzalez-Galvez, Guillermo
    Arechavaleta-Granell, Maria del Rosario
    CURRENT DIABETES REPORTS, 2024, 24 (07) : 158 - 166
  • [50] Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation
    Yang, Mengmeng
    Xia, Longqing
    Song, Jia
    Hu, Huiqing
    Zang, Nan
    Yang, Jingwen
    Zou, Ying
    Wang, Liming
    Zheng, Xiaoyue
    He, Qin
    Liu, Jidong
    Liu, Fuqiang
    Liang, Kai
    Sun, Lei
    Chen, Li
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)